Robert Leslie Holland
Keine laufenden Positionen mehr
Profil
Robert Leslie Holland formerly worked at Newron Pharmaceuticals SpA, as Independent Non-Executive Director from 2013 to 2021, Karolinska Development AB, as Non-Executive Director, Early Clinical Development Consulting Ltd., as Director, Oxford Gene Technology Ltd., as Chief Medical Officer, and AstraZeneca SpA, as Vice President & Head-Personalized Healthcare from 2010 to 2012.
Dr. Holland received his doctorate degree from the University of Oxford.
Ehemalige bekannte Positionen von Robert Leslie Holland
| Unternehmen | Position | Ende |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Director/Board Member | 31.12.2021 |
| Early Clinical Development Consulting Ltd. | Director/Board Member | 01.01.2018 |
Oxford Gene Technology Ltd.
 Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Corporate Officer/Principal | 01.01.2012 |
| KAROLINSKA DEVELOPMENT AB | Director/Board Member | - |
Ausbildung von Robert Leslie Holland
| University of Oxford | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| Private Unternehmen | 3 |
|---|---|
Oxford Gene Technology Ltd.
Oxford Gene Technology Ltd. Miscellaneous Commercial ServicesCommercial Services Oxford Gene Technology Ltd. develops arrays used in genomics research. It engages in providing services to the pharmaceutical and other sectors in making DNA arrays known as in-situ synthesis of oligonucleotide robes. The company was founded by Edwin Southern in 1995 and is headquartered in Begbroke, the United Kingdom. | Commercial Services |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
| Early Clinical Development Consulting Ltd. |
